Dawei Chen

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 6

Top Topics

Acute Lymphoblastic Leukemia

Cell Proliferation

Top Venues

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

The EMBO journal

This page only lists publications with an associated author ORCID identifier.

Publications

Panpan Feng, Dawei Chen, Xia Wang, Yanxia Li, Zhenyu Li, Boya Li, Yupeng Zhang, Wei Li, Jingru Zhang, Jingjing Ye, Baobing Zhao, Jing Xin Li, Chun-Yan Ji
Inhibition of the m 6 A reader IGF2BP2 as a strategy against T-cell acute lymphoblastic leukemia. Leukemia 36 (9) (2022)
Xia Wang, Shuai Xu, Dawei Chen
Reply to the Comment on "The m6A Reader IGF2BP2 Regulates Macrophage Phenotypic Activation and Inflammatory Diseases by Stabilizing TSC1 and PPARγ". Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9 (25) (2022)
Cuiyu Zhang, Yu-Ping Zhou, Junjie Zheng, Nannan Ning, Haining Liu, Wenyang Jiang, Xin Yu, Kun Mu, Yan Li, Wei Guo, Huili Hu, Jing Xin Li, Dawei Chen
Inhibition of GABAA receptors in intestinal stem cells prevents chemoradiotherapy-induced intestinal toxicity. The Journal of experimental medicine 219 (12) (2022)
Dawei Chen, Ivan Nemazanyy, Olivier Peulen, Kateryna Shostak, Xinyi Xu, Seng Chuan Tang, Caroline P Wathieu, Silvia Turchetto, Sylvia Tielens, Laurent Nguyen, Pierre Close, Christophe Desmet, Sebastian Klein, Alexandra Florin, Reinhard Buttner, Georgios Petrellis, Benjamin G Dewals, Alain Chariot
Elp3-mediated codon-dependent translation promotes mTORC2 activation and regulates macrophage polarization. The EMBO journal 41 (18) (2022)
Xia Wang, Yuge Ji, Panpan Feng, Rucheng Liu, Guosheng Li, Junjie Zheng, Yaqiang Xue, Yaxun Wei, Chunyan Ji, Dawei Chen, Jingxin Li
The m6A Reader IGF2BP2 Regulates Macrophage Phenotypic Activation and Inflammatory Diseases by Stabilizing TSC1 and PPARγ. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 8 (13) (2021)
Wei Guo, Cuiyu Zhang, Panpan Feng, Mingying Li, Xia Wang, Yuan Xia, Dawei Chen, Jing Xin Li
M6A methylation of DEGS2, a key ceramide-synthesizing enzyme, is involved in colorectal cancer progression through ceramide synthesis. Oncogene 40 (40) (2021)